Mirati Therapeutics, Inc. (NASDAQ:MRTX) Q2 2023 Earnings Call Transcript
Mirati Therapeutics, Inc. (NASDAQ:MRTX) Q2 2023 Earnings Call Transcript August 8, 2023 Mirati Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-3.04 EPS, expectations were $3.23.






